Chanelle Pharma Partners with SAP to Accelerate Global Growth and Advance Pharmaceutical Manufacturing Excellence
Published: 27 Mar 2026
Author: Precedence Research
Chanelle Pharma, a global pharmaceutical leader in human and animal health, announced a strategic partnership with SAP, the global leader in enterprise software solutions. This collaboration aims to accelerate Chanelle Pharma’s global growth and enhance pharmaceutical manufacturing excellence due to digital transformation.
Vice President for Industries SAP’s Executive John Graham stated, Chanelle Pharma’s commitment to innovation aligns perfectly with SAP’s vision for the future of manufacturing. It can set a new benchmark for digital excellence in the pharmaceutical sector. He also noted the solution includes embedded AI capabilities for predictive analytics and quality control.
According to Towards Healthcare, the Pharmaceutical ERP Market is projected to experience significant growth, with estimates suggesting the market size will increase from USD 3.33 billion in 2026 to approximately USD 9.66 billion by 2035, representing a compound annual growth rate (CAGR) of 12.56% from 2026 to 2035. This initiative represents a major investment in building a modern, scalable digital foundation designed to accelerate time-to-market for innovative medicines, elevate operational visibility, and proactively enhance data governance. It promises to integrate cutting-edge SAP technologies for smarter, compliant production processes across Chanelle’s international footprint.
Chanelle Pharma Chooses SAP for Global Growth
The company has 1800 employees and generates annual revenues exceeding €500 million, and faced challenges in managing its 12 production sites across Ireland, the UK, France, and Asia amid surging global demand for veterinary products. SAP’s cloud-native solutions provide the agility and scalability we need to penetrate new markets in Latin America and Asia-Pacific. This highlighted Chanelle’s export revenues have doubled, necessitating this digital leap.
SAP’s pre-configured industry cloud for pharma, which is a set of ready-to-use cloud-based tools specifically designed for pharmaceutical companies, reduces implementation time by 50% compared to older, traditional software systems.
Aiden Dempsey, CIO, Chanelle Pharma, said this strategic partnership with SAP marks a pivotal moment in our growth trajectory. We are investing heavily in a scalable digital foundation that will accelerate our time-to-market and drive global manufacturing excellence.
Boosting Chanelle’s Manufacturing Efficiency
In manufacturing, the partnership introduces Industry 4.0 elements such as IoT-enabled equipment monitoring and real-time quality assurance. SAP’s platform facilitates serialisation and track-and-trace functionalities, which are important for combating counterfeit drugs in veterinary markets.
Chanelle’s Chief Operating Officer, Dr Elena Vasquez, stated SAP’s tools will enable predictive maintenance, cutting downtime by an estimated 25-30% and reducing waste in our high-volume production lines for antiparasitic and vaccines.
A recent report by Towards Healthcare highlights that the Pharmaceutical ERP Market, SAP’s Cloud ERP, strengthens organisational resilience and governance processes and provides data insights from across the business. This empowers Chanelle Pharma to operate with agility and remain competitive in a highly regulated global market.